COCH vs BVS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BVS Captures Institutional Edge (2โ2 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Bioventus Inc. Class A Common Stock (BVS) driven by superior Valuation, Growth & Margin while COCH counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, COCH trades at N/M Forward P/E with -10261.0% operating margin (+57.1% YoY revenue) versus BVS at 11.1x Forward P/E and 10.1% operating margin (+2.7% YoY). In options structure, COCH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BVS sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | COCH Revenue | BVS Revenue | COCH Op. Margin | BVS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | N/A | $340M | N/A | 9.2% | BVS |
| FY2020 | N/A | $320M | N/A | 6.6% | BVS |
| FY2021 | N/A | $430M | N/A | 2.8% | BVS |
| FY2022 | $0M | $510M | -3673.4% | -32.7% | BVS |
| FY2023 | $0M | $510M | -5809.8% | -16.0% | BVS |
| FY2024 | $0M | $570M | -8558.2% | -2.7% | BVS |
| FY2025 | $0M | $570M | -9240.7% | 9.5% | BVS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | COCH | BVS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $51.9M | $681.3M | Larger Scale | BVS |
| Trailing P/E Ratio Valuation | N/M | 12.3x | Lower Multiple | BVS |
| Forward P/E Ratio Valuation | N/M | 11.1x | Lower Multiple | BVS |
| Revenue Growth (YoY) Growth | +57.1% | +2.7% | Higher Growth | COCH |
| Operating Margin (TTM) Profitability | -10261.0% | 10.1% | Higher Margin | BVS |
| Net Profit Margin Profitability | 0.0% | 9.8% | Higher Margin | BVS |
| Return on Equity (ROE) Capital Efficiency | 0.0% | 25.8% | Higher ROE | BVS |
| 52-Week Range Position Momentum | 89% ($0โ$7) | 36% ($6โ$16) | Stronger Trend | COCH |
| Beta / 30D Volatility Risk Regime | 4.94ฮฒ ยท 3352% Vol | 0.85ฮฒ ยท 74% Vol | Lower Realized Risk | BVS |
| Unified Institutional Score Composite Signal | 35.1 / 100 (SELL) | 46.2 / 100 (HOLD) | Higher Composite | BVS |